References
- Borgman MP, Aras O, Geyser-Stoops S, et al. (2009). Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery. Mol Pharm 6:1836–47
- Cole SP, Deeley RG. (1998). Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays 20:931–40
- Duncan R, Kopecková-Rejmanová P, Strohalm J, et al. (1987). Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer 55:165–74
- Engel JB, Schally AV, Dietl J, et al. (2007). Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones. Mol Pharm 4:652–8
- Greish K, Ray A, Bauer H, et al. (2011). Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy. J Contr Rel 151:263–70
- Kopecek J, Kopeckova P. (2010). HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev 62:122–49
- Lammers T, Peschke P, Kuhnlein R, et al. (2007). Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems. J Contr Rel 117:333–41
- Liu J, Kopeckova P, Buhler P, et al. (2009). Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells. Mol Pharm 6:959–70
- Mammen M, Choi S-K, Whitesides GM. (1998). Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angewandte Chemie Int Ed 37:2754–94
- Mitra A, Coleman T, Borgman M, et al. (2006). Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting. J Contr Rel 114:175–83
- Olsen JO, Pozderac RV, George H, et al. (1995). Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan). Semin Nucl Med 25:251–61
- Rathi RC, Kopečková P, Říhová B, Kopeček J. (1991). N-(2-hydroxypropyl) methacrylamide copolymers containing pendant saccharide moieties: synthesis and bioadhesive properties. J Polym Sci Part A: Polym Chem 29:1985–902
- Rejmanová P, Labský J, Kopeček J. (1977). Aminolyses of monomeric and polymeric p-nitrophenyl esters of methacryloylated amino acids. Die Makromolekulare Chemie 178:2159–68
- Reubi JC, Schaer JC, Waser B, Mengod G. (1994). Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 54:3455–9
- Rihova B. (1998). Receptor-mediated targeted drug or toxin delivery. Adv Drug Deliv Rev 29:273–89
- Shen H, Hu D, Du J, et al. (2008). Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice. Eur J Pharmacol 601:23–9
- Singh SP, Han L, Murali R, et al. (2011). SSTR2-based reporters for assessing gene transfer into non–small cell lung cancer: evaluation using an intrathoracic mouse model. Human Gene Ther 22:55–64
- Subr V, Strohalm J, Ulbrich K, et al. (1992). Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo. J Contr Rel 18:123–32
- Tomáš Etrych, Tomáš Mrkvan, Petr Chytil, et al. (2008). N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. i. new synthesis, physicochemical characterization and preliminary biological evaluation. J Appl Polym Sci 109:3050–61
- Ulbrich K, Subr V, Strohalm J, et al. (2000). Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation. J Contr Rel 64:63–79
- van Brakel R, Vulders RC, Bokdam RJ, et al. (2008). A doxorubicin prodrug activated by the staudinger reaction. Bioconjug Chem 19:714–18
- Watt HL, Kharmate G, Kumar U. (2008). Biology of somatostatin in breast cancer. Mol Cell Endocrinol 286:251–61
- Yang Y, Zhou Z, He S, et al. (2012). Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates. Biomaterials 33:2260–71
- Yuan F, Qin X, Zhou D, et al. (2008). In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer–5-fluorouracil conjugates. Eur J Pharm Biopharm 70:770–6
- Zhang J, Jin W, Wang X, et al. (2010). A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models. Mol Pharm 7:1159–68